- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01796119
Ridge Expansion in the Maxillary Aesthetic Zone Using Piezo-electric Surgery
Lateral Alveolar Ridge Expansion in the Maxillary Aesthetic Zone Using Piezo-electric Surgery and Threaded Osteotomes for Immediate Implant Placement.
In this split-mouth controlled study, implants placed using the alveolar ridge expansion technique will be compared to those placed in native bone with sufficient horizontal bone width.
The Piezosurgery device and Bone expanders (Mectron,Italy) will be employed in an alveolar ridge expansion technique.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The success rate of endosseous implant placement in native bone has been proven to be highly predictable. Reliable long term result requires sufficient bone thickness surrounding the implant's body. This is especially true in the maxillary aesthetic zone where buccal bone thickness of 2mm or more is necessary to prevent loss of buccal bone margin and maintain the integrity of the gingival architecture.
Ridge expansion technique, an alternative to bone graft, widens the alveolar ridge prior to implant placement, thus permits the preservation of buccal and lingual bone thickness.
Narrow atrophy edentulous alveolar ridges (study site) in the maxillary aesthetic zone will be split lengthwise using piezo-electric surgery (Piezosurgery, Mectron, USA). The prepared osteotomy will subsequently be expanded using threaded osteotomes (Bone Expanders, Mectron, Italy). Implants will immediately be inserted in the prepared osteotomy. In the edentulous alveolar ridges with sufficient thickness (controlled site) in the maxillary aesthetic zone, implants will be placed directly using conventional drilling technique. Outcome measures will be compared.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Brossard, Quebec, Canada, J4W2T4
- Clinique Dentaire et d'implantology Dr. Vinh Nguyen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 18 years of age
- Systemically healthy
- Implant therapy will be the elective treatment option.
- The alveolar ridge thickness will be insufficient to receive implant of 3.5-4.3mm in diameter.
- The ridge width will be at least 4mm
- Implants will be placed in the maxillary edentulous ridge from second premolar to the opposite second premolar.
- There will be a second edentulous ridge in the same individual's mouth that serves as control site. The crest of this site will be at least 5.5mm wide, sufficient to receive an implant of 3.5-4.3 mm in diameter.
- Demonstrated ability to maintain oral hygiene
- Willingness and ability to commit to follow-up
- Able to understand study procedure and provide signed informed consent.
- In order to ensure optimal efficacy of the methods used to reduce the risk of pregnancy in female subjects and potential harm to a fetus, contraceptive measures are required in order to participate in the Study, as follows: hormonal methods and the IUD must be in used at least 30 days prior to Study drug administration; that barrier methods must be use in used at least 15 days prior to Study drug administration; that vasectomy must be completed 3 months prior to first Study drug administration; or in the alternative that a 0 sperm count will suffice.
Exclusion Criteria:
- Extreme alveolar ridge atrophy with no cancellous bone between the buccal and palatal cortical plates
- Extensive vertical ridge resorption which requires vertical augmentation
- Uncontrolled periodontal disease.
- Need of sinus lift procedures in the site of intended implant placement.
- Recent febrile illness (within 6 months) that precludes or delays participation
- Wearers of pacemaker.
- Severe renal or liver diseases
- History of radiotherapy of the head and neck region
- Chemotherapy for treatment of malignant tumors at the time of the study.
- Immuno-compromised patients
- Patients on IV bisphosphonates or on long term oral bisphosphonates for more than 3 years.
- Use of disallowed concomitant medications.
- Pregnancy or intending to conceive during the course of the Study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ridge Splitting
Dental implants placed using ridge splitting technique. To measure the horizontal bone width before and after implant insertion and 6 months post-op. To measure BLI measured using PA radiographs taken immediately and 6 months post-op. To measure implant stability with the resonance frequency analyzer (Osstell,Osstell USA) at time of implant placement, 3 months and 6 months post-op. To measure implant success rate. The implants used in this study: NobelActive 3.5 - 4.3mm diameter, 10 - 13 mm in length. |
To measure the horizontal bone width before and after implant insertion and 6 months post-op. To measure BLI measured using PA radiographs taken immediately and 6 months post-op. To measure implant stability with the resonance frequency analyzer (Osstell,Osstell USA) at time of implant placement, 3 months and 6 months post-op. To measure implant success rate. The implants used in this study: NobelActive 3.5 - 4.3mm diameter, 10 - 13 mm in length. |
|
Active Comparator: Implants placed using drilling technique
Dental implants placed in the ridge with sufficient thickness using drilling technique. To measure the horizontal bone width before and after implant insertion and 6 months post-op. To measure BLI measured using PA radiographs taken immediately and 6 months post-op. To measure implant stability with the resonance frequency analyzer (Osstell,Osstell USA) at time of implant placement, 3 months and 6 months post-op. To measure implant success rate. The implants used in this study: NobelActive 3.5-4.3mm diameter, 10 - 13 mm in length. |
To measure the horizontal bone width before and after implant insertion and 6 months post-op. To measure BLI measured using PA radiographs taken immediately and 6 months post-op. To measure implant stability with the resonance frequency analyzer (Osstell,Osstell USA) at time of implant placement, 3 months and 6 months post-op. To measure implant success rate. The implants used in this study: NobelActive 3.5-4.3mm diameter, 10 - 13 mm in length. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bucco-lingual bone thickness of the alveolar ridge
Time Frame: 6 months
|
To compare the bucco-lingual thickness of the alveolar ridge measured at approximately 1 mm.
and 5 mm.
below the crestal bone margin, using ridge mapping calipers.
These values, measured pre-op, immediately, and 6 months post-op at study site are compared to those measured from controlled site.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare BLI measured using PA radiographs
Time Frame: 6 months
|
To compare BLI measured using PA radiographs taken immediately, and 6 months post-op at study site.
These values are also compared to those measured from controlled site.
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implant Stability Quotient Values
Time Frame: 3, 6 months
|
Implant Stability Quotient Values (Osstell ISQ, Osstell USA) obtained from implants in study site, recording immediately, 3 months and 6 months post-op to evaluate implant stability.
These values will also be compared to those obtained from implants placed in controlled site
|
3, 6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Vinh Nguyen, DDS., Goethe University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB1665
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Loss
-
Erasmus Medical CenterUniversity Medical Center Groningen; University of Santiago de CompostelaRecruitingTooth Loss / RehabilitationNetherlands
-
University of BelgradeInstitute Straumann AG, Basel, SwitzerlandActive, not recruitingTooth Loss / Rehabilitation | MaxillaSerbia
-
Institut Straumann AGCompleted
-
Universidad Complutense de MadridRecruitingPartial Edentulism | Tooth Loss / RehabilitationSpain
-
Duygu KarasanHacettepe UniversityCompleted
-
Murad AlrashidiNot yet recruitingSpace Maintenance | Tooth Loss / RehabilitationSaudi Arabia
-
University of AarhusCompleted
-
University of GuarulhosCompletedTooth Decay | Tooth Loss / Rehabilitation | Caries Active
-
Akdeniz UniversityCompletedAlveolar Bone Loss | Tooth Loss / RehabilitationTurkey (Türkiye)
-
Cairo UniversityNot yet recruitingLoss of Teeth Due to ExtractionEgypt
Clinical Trials on Ridge Splitting
-
Al-Azhar UniversityCompletedKnife Edge Alveolar RidgeEgypt
-
Kafrelsheikh UniversityCompletedAlveolar Bone Resorption | Dental Implant Failure NosEgypt
-
Kafrelsheikh UniversityRecruitingReconstruction of Horizontal Ridge DefectsEgypt
-
Cairo UniversityUnknownAtrophy; Edentulous Ridge
-
Mansoura UniversityCompletedAlveolar Ridge AugmentationEgypt
-
Cairo UniversityUnknownAlveolar Ridge AugmentationEgypt
-
Hams Hamed AbdelrahmanCompleted
-
Lydia NabilCompletedAlveolar Process AtrophyEgypt
-
Mansoura UniversityCompletedRidge SplittingEgypt
-
Hams Hamed AbdelrahmanCompleted